Data as of .
LFSC vs XT: which is really different?
LFSC and XT hold 0% of their weight in the same names, and LFSC returned more over the year.
ETFIQ Off-Index Score: LFSC scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, LFSC and XT hold 0% of their money in the same securities at the same weight.
| Holding | LFSC | XT |
|---|---|---|
| Guardant Health Inc | 5.51% | 0.13% |
| Bridgebio Pharma Inc | 1.17% | 0.06% |
| Only in LFSC | Only in XT |
|---|---|
| Travere Therapeutics Inc 7.66% | MICROSOFT 4.19% |
| Cogent Biosciences Inc 7.52% | NVIDIA 4.13% |
| LivaNova PLC 7.11% | ELI LILLY 3.94% |
| Spyre Therapeutics Inc 6.41% | TESLA INC 3.52% |
| Mirum Pharmaceuticals Inc 4.92% | TEXAS INSTRUMENT INC 3.49% |
| Corcept Therapeutics Inc 4.79% | JOHNSON & JOHNSON 3.47% |
| United Therapeutics Corp 4.15% | PALO ALTO NETWORKS 2.99% |
| VeraDermics Inc 3.42% | ANALOG DEVICES 2.85% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated May 31, 2026 and Sep 17, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| LFSC | XT | LFSC | XT | LFSC | XT | |
| 3 months | +8.7% | 0.0% | +6.5 pts | −2.3 pts | +11.2 pts | +2.5 pts |
| 6 months | +36.0% | +22.9% | +17.9 pts | +4.8 pts | +11.7 pts | −1.4 pts |
| 1 year | +53.0% | +24.4% | +36.5 pts | +7.8 pts | +31.3 pts | +2.6 pts |
| 3 years | not published | +67.9% | not published | −10.5 pts | not published | −30.2 pts |
| Since launch | +81.3% | +284.5% | +44.3 pts | −56.6 pts | +30.9 pts | −342.6 pts |
| LFSC F/m Emerald Life Sciences Innovation ETF Holds 39 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companies | XT iShares Future Exponential Technologies ETF Holds 225 stocks in broad innovation and megatrends, 64% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | F/m | iShares |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 0.0% | 64.5% |
| Active share vs the S&P 500 | 100.0% | 67.5% |
| In the Nasdaq-100 | 0.6% | 39.4% |
| Holdings | 39 | 225 |
| Top ten, share of the fund | 54.7% | 33.9% |
| Expense ratio | 0.54% | 0.46% |
| Fee for the differing part | 0.54% | 0.68% |
| Total return, 1 year | +53.0% | +24.4% |
| vs the S&P 500 | +36.5 pts | +7.8 pts |
| vs the Nasdaq-100 | +31.3 pts | +2.6 pts |
| Below its high | −6.8% | −1.9% |
| Net assets | $105m | $4.0bn |
LFSC in plain words
By weight, 0% of LFSC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 55% of the fund across 39 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +53.0% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 36.5 pts. It sits 6.8% below its all-time high of Aug 19, 2026.
XT in plain words
By weight, 64% of XT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 68%. The top ten holdings are 34% of the fund across 225 positions, as published by its issuer for Sep 17, 2026. Over the year to Sep 18, 2026 the fund returned +24.4% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 7.8 pts.
Questions people ask
- Do LFSC and XT hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, LFSC or XT?
- LFSC has 0% of its weight in S&P 500 names and XT has 64%, so LFSC differs more from the index.
- Which is cheaper, LFSC or XT?
- LFSC charges 0.54% a year and XT charges 0.46%, so XT is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, LFSC against XT, data as of Sep 18, 2026. https://etfiq.com/compare/themes/lfsc-vs-xt Free to use with attribution; the underlying files are at Open data.